Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1249, 2000-01, pp. : 19-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
By Scheen A.J.
Drug Safety, Vol. 24, Iss. 12, 2001-01 ,pp. :
Access to resources
Recommend
Reduced potential for hepatotoxicity with newer thiazolidinediones?
Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. :
Rifampicin/pyrazinamide: risk of hepatotoxicity variable?
Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. :
Hepatotoxicity in patients taking rosiglitazone: is it drug-induced?
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :
All smoke and no fire with amfebutamone?
Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. :